Cargando…
EPAS1 targeting by miR-152-3p in Paclitaxel-resistant Breast Cancer
Background: Paclitaxel plays a pivotal role in the chemotherapy of breast cancer, but resistance to this drug is an important obstacle in the treatment. It is reported that microRNA-152-3p (miR-152-3p) is involved in tamoxifen resistance in breast cancer, but whether it is involved in paclitaxel res...
Autores principales: | Song, Ying, Zhang, Mo, Lu, Man Man, Qu, Li Yuan, Xu, Si Guang, Li, Yong Zhen, Wang, Ming Yong, Zhu, Hui Fang, Zhang, Zhe Ying, He, Guo Yang, Yuan, Zhi Qing, Li, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477434/ https://www.ncbi.nlm.nih.gov/pubmed/32913475 http://dx.doi.org/10.7150/jca.46898 |
Ejemplares similares
-
Expression of miR-148/152 Family as Potential Biomarkers in Non-Small-Cell Lung Cancer
por: Li, Li, et al.
Publicado: (2015) -
Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022) -
Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro
por: Li, Li, et al.
Publicado: (2019) -
miR-152-3p Represses the Proliferation of the Thymic Epithelial Cells by Targeting Smad2
por: Li, Ying, et al.
Publicado: (2022) -
miR-152-mediated MKK7 downregulation is attenuated by MYCNOS in ovarian adenocarcinoma
por: Zhang, Guifang, et al.
Publicado: (2021)